Medical Technology with YOU at the center
About Odigent
Pioneering
Peripheral Nerve Health
Technology
Through Innovation
Odigent is a Los Angeles–based medical technology company pioneering innovations at the intersection of biotechnology, artificial intelligence, and human health. We specialize in developing advanced devices that build around:
-
Neuropathy symptom reduction
-
Microcirculation enhancement
-
Sensory regulation
-
Nerve stress mitigation
Our Mission
Our mission is to lead the future of peripheral nerve health by creating integrated, wearable technologies that support human adaptability, performance, and functional independence.
Our Approach
Our platform integrates advanced material layering, structured thermal regulation, and precision compression architecture to create stable, controlled micro-environments around sensitive nerve regions. By reducing external stressors and supporting natural physiological balance, our technologies aim to enhance comfort, functional performance, and long-term resilience.
Your whole life is contained in this single cell. Your DNA gives the code, your genes provide the instructions to create proteins, your proteins make the cell. In a perfect world...
What if we could collapse the network that tumors create to grow and spread? What if we could tell you, based on your mutation grouping, all there is to know about your cancer/tumor so your treatments can be more personalized? THAT'S OUR BRIGHT IDEA!!
Our Innovations
Current Projects
Colon Mapping System
A laser-mapping colonoscope integrates real-time optical scanning with micro-sampling to create a 3D, coordinate-tagged atlas of the colon. A low-power scanning laser system (OCT / Confocal / Raman) maps the mucosal surface while a micro-aspiration or soft brush port collects superficial cells from mapped regions. Each cell sample is automatically linked to its exact spatial location within the colon for genomic, proteomic, or microbiome analysis.
Peripheral Nerve Rehabilitation Platform
The Peripheral Nerve Rehabilitation Platform is a sleek, lifestyle-oriented wearable designed to help chemotherapy patients manage cold-induced neuropathy. By combining advanced materials with ergonomic design, it provides continuous protection and warmth without sacrificing mobility or style. This glove integrates space-age insulation and heat-retaining fabrics into a minimalist, everyday form suitable for cooking, housework, or outdoor use.
M.S.S.I. Initiative
Master Survival Switch Inhibitor (MSSI): A Unified Strategy to Suppress ERK- and NF-kB-Dependent Anti-Apoptotic Networks in Apoptosis-Resistant Solid Tumors. A subset of solid tumors exhibit profound resistance to chemotherapy through activation of MAPK/ERK,, NF-kB, and CDK9-dependent survival transcription. These pathways stabilize anti-apoptotic proteins MCL-1, BCL-XL, Survivin, XIAP, and c-FLIP. Tumors with NRAS/KRAS activation, APC loss, TP53 loss, and SMAD4 loss depend heavily on this survival cluster. We are developing a unified upstream strategy needed to collapse this network.
C.R.A.E. (pronounced "cray")
CRAE (Cancer Recurrence Architecture Engine) transforms genomic, pathology, staging, and treatment data into a personalized, educational model of recurrence architecture using A.I.It explains how a patient’s cancer behaves biologically — without diagnosing or guiding treatment.
